Session 3.2: Viral Clearance of Emerging Unit Operations: Membrane Chromatography, Other Methods, Etc.

References

1. 1.↵
   1. Stuckey J.,
   2. Strauss D.,
   3. Venkiteshwaran A.,
   4. Gao J.,
   5. Luo W.,
   6. Quertinmont M.,
   7. O'Donnell S.,
   8. Chen D.

   A Novel Approach to Achieving Modular Retrovirus Clearance for a Parvovirus Filter. Biotechnol. Prog. 2014, 30 (1), 79–85.

   OpenUrlCrossRefGoogle Scholar
2. 2.↵
   1. Venkiteshwaran A.,
   2. Fogle J.,
   3. Patnaik P.,
   4. Kowle R.,
   5. Chen D.

   Mechanistic Evaluation of Virus Clearance by Depth Filtration. Biotechnol. Prog. 2014, 31 (1), 431–437.

   OpenUrlGoogle Scholar
3. 3.↵
   1. Kang Y. K.,
   2. Hamzik J.,
   3. Felo M.,
   4. Qi B.,
   5. Lee J.,
   6. Ng S.,
   7. Liebisch G.,
   8. Shanehsaz B.,
   9. Singh N.,
   10. Persaud K.,
   11. Ludwig D. L.,
   12. Balderes P.

   Development of a Novel and Efficient Cell Culture Flocculation Process Using a Stimulus Responsive Polymer to Streamline Antibody Purification Processes. Biotechnol. Bioeng. 2013, 110 (11), 2928–2937.

   OpenUrlGoogle Scholar
4. 4.↵
   1. Liumbruno G. M.,
   2. Marano G.,
   3. Grazzini G.,
   4. Capuzzo E.,
   5. Franchini M.

   Solvent/Detergent-Treated Plasma: A Tale of 30 Years of Experience. Expert Rev. Hematol. 2015, 8 (3), 367–374.

   OpenUrlPubMedGoogle Scholar
5. 5.↵
   International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guidance of Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin, Q5A. Federal Register 1998, 63, 51074–51084.

   OpenUrlPubMedGoogle Scholar
6. 6.↵
   1. Miesegaes G.,
   2. Lute S.,
   3. Brorson K.

   Analysis of Viral Clearance Unit Operations for Monoclonal Antibodies. Biotechnol. Bioeng. 2010, 106 (2), 238–246.

   OpenUrlPubMedGoogle Scholar
7. 7.↵
   1. Miesegaes G.,
   2. Lute S.,
   3. Reed E.,
   4. Brorson K.

   Viral Clearance by Flow-Through Mode Ion Exchange Columns and Membrane Adsorbers. Biotechnol. Prog. 2014, 14 (1), 124–131.

   OpenUrlGoogle Scholar
8. 8.↵
   1. Hubbard B.

   Viral Clearance Symposium Session 1.5: Other Viral Clearance and Inactivation Approaches (Multimodal Chromatography, Membrane Chromatography, Chemical Precipitation). PDA J. Pharm. Sci. Technol. 2015, 69 (1), 173–182.

   OpenUrlFREE Full TextGoogle Scholar
9. 9.↵
   1. Lute S.

   An Update of the FDA Viral Clearance Database. 2015 PDA Virus & TSE Safety Forum, Lisbon, Portugal.

   Google Scholar
10. 10.↵
    1. Zhou J.,
    2. Tressel T.

    Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol. Prog. 2006, 22 (2), 341–349.

    OpenUrlPubMedGoogle Scholar
11. 11.↵
    PDA Technical Report No. 47. Parenteral Drug Association: Bethesda, MD, 2010.

    Google Scholar